Fusion between CLDN18, a tight junction gene, and ARHGAP26, a gene encoding an RHOA inhibitor, was first reported by the Cancer Genome Atlas to be enriched in the genomically stable subtype of GC [33]. Here, CLDN18 is linked to gastric cancer.